Clovis Oncology, Inc.

Clovis Oncology, Inc.verified

CLVS

Price:

$0.0812

Market Cap:

$0

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the company offers Rubraca for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is also developing lucitanib, an investigational angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through ...[Read more]

Industry

Biotechnology

IPO Date

2011-11-16

Stock Exchange

NASDAQ

Ticker

CLVS

The PE Ratio as of June 2024 (TTM) for Clovis Oncology, Inc. (CLVS) is -0.04

According to Clovis Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -96.21% compared to the average of -1.03 of the last 4 quarters.

Clovis Oncology, Inc. (CLVS) Historical PE Ratio (quarterly & annually)

How has CLVS PE Ratio performed in the past?

The mean historical PE Ratio of Clovis Oncology, Inc. over the last ten years is -6.17. The current -0.04 PE Ratio has changed -36.83% with respect to the historical average. Over the past ten years (40 quarters), CLVS's PE Ratio was at its highest in in the September 2019 quarter at -0.57. The PE Ratio was at its lowest in in the June 2013 quarter at -24.05.

Quarterly (TTM)
Annual

Average

-6.17

Median

-4.23

Minimum

-20.44

Maximum

-1.10

Clovis Oncology, Inc. (CLVS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clovis Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 451.40%

Maximum Annual PE Ratio = -1.10

Minimum Annual Increase = -72.49%

Minimum Annual PE Ratio = -20.44

Quarterly (TTM)
Annual
YearPE RatioChange
2021-1.2413.30%
2020-1.10-21.85%
2019-1.40-44.80%
2018-2.54-72.49%
2017-9.2488.66%
2016-4.9037.00%
2015-3.57-69.87%
2014-11.86-41.99%
2013-20.44279.39%
2012-5.39451.40%

Clovis Oncology, Inc. (CLVS) Average PE Ratio

How has CLVS PE Ratio performed in the past?

The current PE Ratio of Clovis Oncology, Inc. (CLVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.25

5-year avg

-3.10

10-year avg

-6.17

Clovis Oncology, Inc. (CLVS) PE Ratio vs. Peers

How is CLVS’s PE Ratio compared to its peers?

Clovis Oncology, Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Clovis Oncology, Inc. (CLVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clovis Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clovis Oncology, Inc. (CLVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clovis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Clovis Oncology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Clovis Oncology, Inc. (CLVS)?

What is the highest PE Ratio for Clovis Oncology, Inc. (CLVS)?

What is the 3-year average PE Ratio for Clovis Oncology, Inc. (CLVS)?

What is the 5-year average PE Ratio for Clovis Oncology, Inc. (CLVS)?

How does the current PE Ratio for Clovis Oncology, Inc. (CLVS) compare to its historical average?